Investigation of oral malodor prevention by dentifrices as measured by VSC reduction

Author:

Zsiska Marianne,Schneiderman Eva,Jin Yingkun,Farrell Svetlana,Grender Julie

Abstract

Abstract The oral malodor reduction efficacy of dentifrices containing stannous fluoride (SnF2) or zinc plus arginine (Zn/Arg) was evaluated using a halimeter to measure volatile sulfur compounds (VSCs) in two randomized, controlled, single-blind, cross-over pilot clinical trials. Study 1 (N = 16) had five 1100 ppm F dentifrices and five treatment periods: negative control (NC): 0.243% sodium fluoride (NaF); SnF2 A: 0.454% SnF2 + pyrophosphate; SnF2 B: 0.454% SnF2 + sodium hexametaphosphate; SnF2 C: 0.454% SnF2 + citrate; and SnF2 D: experimental 0.454% SnF2 with increased bioavailable Sn. Study 2 (N = 16) had four 1450 ppm F dentifrices and four treatment periods: NC: 0.1% NaF + 0.76% sodium monofluorophosphate; Zn/Arg: NaF + zinc + arginine; SnF2 E: 0.454% SnF2 + 0.078% NaF + sodium hexametaphosphate; SnF2 F: 0.454% SnF2 + 0.078% NaF + citrate. Each period took 96 h; baseline (day 0) morning to day 4 morning. Subjects brushed 2x/day with the treatment dentifrice. VSC levels were measured in the morning, prior to morning brushing, on days 0 and 4. Changes in VSC scores from day 0 to day 4 were assessed using a mixed-model analysis of covariance for cross-over studies. In study 1, SnF2 dentifrices B, C and D showed statistically significant reductions (31.3%, 24.8%, 34%, respectively) in VSC scores versus baseline (p < 0.001); the benefits of these treatments versus NC and SnF2 dentifrice A were statistically significant (p ⩽ 0.001). In study 2, SnF2 dentifrices E and F showed statistically significant reductions (31.2%, 22.1%, respectively) in VSC scores versus baseline (p ⩽ 0.010); the benefits of these treatments versus NC and the Zn/Arg dentifrice were statistically significant (p ⩽ 0.035). The Zn/Arg dentifrice showed a significant increase of 35.2% (p < 0.001) in VSC scores versus baseline. These studies demonstrated that SnF2 dentifrices can provide significant oral malodor reductions, but the benefit is formulation dependent. The presence of SnF2 is not sufficient to ensure efficacy. The Zn/Arg dentifrice increased VSC levels, indicating greater malodor. Clinical Trial Numbers: 20190429 and 20191028

Funder

The Procter & Gamble Company

Publisher

IOP Publishing

Subject

Pulmonary and Respiratory Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3